Close Menu

    Subscribe to Updates

    Get the latest creative news from Healthradar about News,Health and Gadgets.

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    What's Hot

    I was about to quit my new year fitness push, but these $190 savings on two of Samsung’s best fitness trackers just gave me a second wind

    13. Februar 2026

    Curebound Adds Five Prominent Business Leaders to Board to Accelerate Impactful Cancer Research

    13. Februar 2026

    Hippocratic AI Announces New Key Executive Appointments to Further Accelerate Growth

    13. Februar 2026
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram Pinterest Vimeo
    healthradar.nethealthradar.net
    • Home
    • Ai
    • Gadgets
    • Health
    • News
    • Contact Us
    Contact
    healthradar.nethealthradar.net
    Home»Health»Hippocratic AI Announces New Key Executive Appointments to Further Accelerate Growth
    Health

    Hippocratic AI Announces New Key Executive Appointments to Further Accelerate Growth

    HealthradarBy Healthradar13. Februar 2026Keine Kommentare3 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Reddit Telegram Email
    Hippocratic AI Announces New Key Executive Appointments to Further Accelerate Growth
    Share
    Facebook Twitter LinkedIn Pinterest Email


    Additional Executive Hires to Support Safe, Responsible Scaling of Generative AI Healthcare Agents

    PALO ALTO, Calif.–(BUSINESS WIRE)–#GenAI–Hippocratic AI, a global leader and pioneer of generative AI healthcare agents, today announced several strategic executive appointments as the company continues to scale its platform across providers, payors, and life sciences organizations. The additions strengthen Hippocratic AI’s clinical leadership, operational depth, and go-to-market execution as demand accelerates. The appointments follow Hippocratic AI’s $141 million Series C financing announced in November.

    “As Hippocratic AI scales, building a leadership team grounded in clinical credibility, operational rigor, and patient safety is non-negotiable,” said Munjal Shah, CEO of Hippocratic AI. “ These leaders bring decades of experience across healthcare, AI, and enterprise execution, and they will play a critical role in helping us continue to scale implementation of generative AI healthcare agents responsibly, at scale, and in service of healthcare abundance.”

    New Executive Appointments:

    • Dr. Anoop Sangha, MD, Associate Chief Medical Officer
      Anoop brings more than two decades of clinical practice and physician leadership experience across digital health, payor, and provider organizations. He has held senior clinical leadership roles at Transcarent, Livongo (Teladoc Health), Optum, and the Advisory Board Company, where he helped scale AI-enabled care models, remote patient monitoring, and clinical programs spanning navigation, chronic care, and population health. Dr. Sangha is board-certified in Emergency Medicine and is known for bridging clinical rigor with product, operational, and commercial strategy to drive measurable impact.
    • Dr. Eduardo Reis, MD, Vice President, Strategy (Office of the CEO)
      Eduardo Pontes Reis, MD, has joined Hippocratic AI as part of the Office of the CEO, bringing deep expertise at the intersection of clinical medicine, medical imaging, and artificial intelligence. A neuroradiologist and AI researcher, he has held leadership and research roles at Stanford’s Center for Artificial Intelligence in Medicine and Imaging (AIMI) and Hospital Israelita Albert Einstein, where he has focused on building, evaluating, and deploying AI systems for real-world clinical use. Recently, he has served as Founding Radiologist at a fast-growing radiology AI startup, acquired by a large radiology group. Dr. Reis brings a strong track record in medical AI to support Hippocratic AI’s executive strategy and product development.
    • Niloy Sanyal, Chief Marketing Officer
      Niloy brings over 20 years of experience building and scaling healthcare, AI, and enterprise SaaS companies, with a track record of shaping category-defining brands and driving sustained growth in highly regulated markets. He has held senior leadership roles at LeanTaaS, Omnicell, and GE Digital, where he led global marketing and go-to-market functions, launched enterprise platforms, and partnered closely with product and sales teams to accelerate adoption across health systems and life sciences organizations. Across these roles, Niloy is known for translating complex technologies into clear value propositions, building high-performing teams, and establishing durable market leadership.

    These appointments reinforce Hippocratic AI’s commitment to building safe generative AI healthcare agents that improve access and health outcomes as the company continues to scale.

    About Hippocratic AI

    Hippocratic AI has developed the safest generative AI Agents for healthcare. The company believes that generative AI has the ability to bring healthcare abundance to every person in the world. The company focuses on building non-diagnostic patient-facing clinical AI agents and does not allow its agents to be used to prescribe or diagnose. Hippocratic AI has received a total of $404 million in funding and is backed by leading investors, including Andreessen Horowitz, General Catalyst, Kleiner Perkins, Avenir, NVIDIA’s NVentures, Premji Invest, SV Angel, Google’s CapitalG, and numerous health systems. Learn more at https://hippocraticai.com/.

    Contacts

    Media Contact
    Rick Keating
    press@hippocraticai.com





    Source link

    Accelerate announces Appointments Artificial Intelligence Digital Health Transformation Executive growth Hippocratic Key Press Release
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleCareDx Announces Clinical Validation Results for AlloHeme™, the First AI‑Powered NGS Surveillance Solution for AML and MDS Post‑Cell Therapy
    Next Article Curebound Adds Five Prominent Business Leaders to Board to Accelerate Impactful Cancer Research
    ekass777x
    Healthradar
    • Website

    Related Posts

    Health

    I was about to quit my new year fitness push, but these $190 savings on two of Samsung’s best fitness trackers just gave me a second wind

    13. Februar 2026
    Gadgets

    Curebound Adds Five Prominent Business Leaders to Board to Accelerate Impactful Cancer Research

    13. Februar 2026
    Gadgets

    CareDx Announces Clinical Validation Results for AlloHeme™, the First AI‑Powered NGS Surveillance Solution for AML and MDS Post‑Cell Therapy

    13. Februar 2026
    Add A Comment
    Leave A Reply Cancel Reply

    Top Posts

    Garmin Venu 4: Everything we know so far about the premium smartwatch

    7. August 202587 Views

    Nanoleaf LED face mask review: fantastic value for money, but only by cutting some corners

    16. Oktober 202554 Views

    The Top 3 Tax Mistakes High-Earning Physicians Make

    7. August 202536 Views

    Dexcom raises sales expectations, discusses G8 plans

    31. Juli 202525 Views
    Stay In Touch
    • Facebook
    • YouTube
    • TikTok
    • WhatsApp
    • Twitter
    • Instagram
    Latest Reviews

    Subscribe to Updates

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    About Us

    Welcome to HealthRadar.net — your trusted destination for discovering the latest innovations in digital health. We are dedicated to connecting individuals, healthcare professionals, and organizations with cutting-edge tools, applications

    Most Popular

    Garmin Venu 4: Everything we know so far about the premium smartwatch

    7. August 202587 Views

    Nanoleaf LED face mask review: fantastic value for money, but only by cutting some corners

    16. Oktober 202554 Views
    USEFULL LINK
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    QUICK LINKS
    • Ai
    • Gadgets
    • Health
    • News
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    Copyright© 2025 Healthradar All Rights Reserved.

    Type above and press Enter to search. Press Esc to cancel.